156 related articles for article (PubMed ID: 27325642)
1. CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity.
Boyle SE; Fedele CG; Corbin V; Wybacz E; Szeto P; Lewin J; Young RJ; Wong A; Fuller R; Spillane J; Speakman D; Donahoe S; Pohl M; Gyorki D; Henderson MA; Johnstone RW; Papenfuss AT; Shackleton M
Cancer Res; 2016 Jul; 76(13):3965-77. PubMed ID: 27325642
[TBL] [Abstract][Full Text] [Related]
2. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
Redmer T; Welte Y; Behrens D; Fichtner I; Przybilla D; Wruck W; Yaspo ML; Lehrach H; Schäfer R; Regenbrecht CR
PLoS One; 2014; 9(5):e92596. PubMed ID: 24799129
[TBL] [Abstract][Full Text] [Related]
3. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.
Civenni G; Walter A; Kobert N; Mihic-Probst D; Zipser M; Belloni B; Seifert B; Moch H; Dummer R; van den Broek M; Sommer L
Cancer Res; 2011 Apr; 71(8):3098-109. PubMed ID: 21393506
[TBL] [Abstract][Full Text] [Related]
4. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells.
Morita S; Mochizuki M; Wada K; Shibuya R; Nakamura M; Yamaguchi K; Yamazaki T; Imai T; Asada Y; Matsuura K; Sugamura K; Katori Y; Satoh K; Tamai K
Cancer Lett; 2019 Oct; 461():144-152. PubMed ID: 31325530
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.
Boiko AD; Razorenova OV; van de Rijn M; Swetter SM; Johnson DL; Ly DP; Butler PD; Yang GP; Joshua B; Kaplan MJ; Longaker MT; Weissman IL
Nature; 2010 Jul; 466(7302):133-7. PubMed ID: 20596026
[TBL] [Abstract][Full Text] [Related]
6. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
[TBL] [Abstract][Full Text] [Related]
7. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
8. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study.
Nielsen PS; Riber-Hansen R; Steiniche T
Pathology; 2018 Jun; 50(4):402-410. PubMed ID: 29678478
[TBL] [Abstract][Full Text] [Related]
10. Defective autophagy leads to the suppression of stem-like features of CD271
Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
[TBL] [Abstract][Full Text] [Related]
11. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.
Valyi-Nagy K; Kormos B; Ali M; Shukla D; Valyi-Nagy T
Mol Vis; 2012; 18():588-92. PubMed ID: 22419851
[TBL] [Abstract][Full Text] [Related]
12. Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.
Chai S; Xu X; Wang Y; Zhou Y; Zhang C; Yang Y; Yang Y; Xu H; Xu R; Wang K
Oncotarget; 2015 Jun; 6(18):16069-83. PubMed ID: 25965829
[TBL] [Abstract][Full Text] [Related]
13. Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression.
Saltari A; Dzung A; Quadri M; Tiso N; Facchinello N; Hernández-Barranco A; Garcia-Silva S; Nogués L; Stoffel CI; Cheng PF; Turko P; Eichhoff OM; Truzzi F; Marconi A; Pincelli C; Peinado H; Dummer R; Levesque MP
Cancer Res; 2021 Dec; 81(23):6044-6057. PubMed ID: 34645608
[TBL] [Abstract][Full Text] [Related]
14. CD271 defines a stem cell-like population in hypopharyngeal cancer.
Imai T; Tamai K; Oizumi S; Oyama K; Yamaguchi K; Sato I; Satoh K; Matsuura K; Saijo S; Sugamura K; Tanaka N
PLoS One; 2013; 8(4):e62002. PubMed ID: 23626764
[TBL] [Abstract][Full Text] [Related]
15. low neurotrophin receptor CD271 regulates phenotype switching in melanoma.
Restivo G; Diener J; Cheng PF; Kiowski G; Bonalli M; Biedermann T; Reichmann E; Levesque MP; Dummer R; Sommer L
Nat Commun; 2017 Dec; 8(1):1988. PubMed ID: 29215016
[TBL] [Abstract][Full Text] [Related]
16. Identification of melanoma initiating cells: does CD271 have a future?
Ballotti R
Future Oncol; 2015; 11(11):1587-90. PubMed ID: 26043212
[No Abstract] [Full Text] [Related]
17. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
[TBL] [Abstract][Full Text] [Related]
18. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.
Marconi A; Borroni RG; Truzzi F; Longo C; Pistoni F; Pellacani G; Pincelli C
Exp Dermatol; 2015 May; 24(5):396-8. PubMed ID: 25739328
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain.
Guo R; Fierro-Fine A; Goddard L; Russell M; Chen J; Liu CZ; Fung KM; Hassell LA
Int J Clin Exp Pathol; 2014; 7(12):8947-51. PubMed ID: 25674270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
